UNSPSC 51132100: Combination hematolic drugs

This classification denotes combination drugs that act on blood and blood-forming organs and those that affect the hemostatic system.

UNSPSC 51132100 Combination hematolic drugs, a Class code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record — Sourcewell RFP #061626, posted May 12, 2026 with a response deadline of June 16, 2026 — solicits law enforcement equipment through a cooperative purchasing vehicle, a scope entirely unrelated to pharmaceutical combination therapies or hematologic medications. The mismatch suggests either a classification error in the opportunity record or a data-entry anomaly; the code shows no meaningful recent activity in its stated commodity domain among state and local buyers.

The law enforcement equipment solicitation itself is a multi-jurisdictional cooperative procurement issued by Sourcewell, a Minnesota local government unit and service cooperative, on behalf of participating entities including Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County in Washington state, plus numerous other public bodies across the United States and Canada. The resulting contract framework will serve thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, and tribal governments. Vendors must submit proposals through the Sourcewell Procurement Portal; no set-aside designations, award values, or incumbent information is specified in available documentation. Given the mismatch between the code's pharmaceutical scope and the actual opportunity record, business development professionals should verify the correct UNSPSC classification for law enforcement equipment procurement before pursuing this opportunity or should seek clarification on whether the code designation reflects authentic hematologic-drug procurement activity among state and local buyers.